CRN names new chairman, board of directors

Press enter to search
Close search
Open Menu

CRN names new chairman, board of directors

01/14/2019
Dietary supplement and functional food trade organization the Council for Responsible Nutrition has a new chairman and board of directors. The organization on Monday announced David Campbell, vice president of North America regulatory affairs and policy at RB Health, had been elected chair of the board of directors. Campbell, who served on CRN’s executive committee for the past two years, will hold the chairman position through 2020.

Campbell has more than 20 years of health industry experience, including roles at Pfizer Consumer Health, where he focused on developing and executing regulatory strategy for OTC drugs, medical devices, dietary supplements and cosmetics, and as senior director of North American regional regulatory lead. He also has worked at such companies as Sanofi-Aventi, Daiichi Medical Research, Atlanta Pharma and Watson Pharma.

The full board includes Steve Mister, CRN president and CEO, who serves as an officer, as well as the following, with executive committee appointees denoted by an asterisk.

Manufacturers:

  • Susanne Andersen-Baekgaard, Bifodan;

  • Aaron Bartz, Ortho Molecular Products;

  • Kristen Blanchard, Nutramax Labs;

  • Paul Bolar, Pharmavite;

  • David Campbell, RB Health (U.S.) * (chair);

  • Chad Clawson, Nutraceutical Corporation;

  • Michael Costello, The Clorox Company/Nutranext;

  • Teresa Gonzalez Ruiz, Bayer HealthCare;

  • Mike Devereux, Nature’s Way Brands*;

  • Mike Finamore, Gemini Pharmaceuticals;

  • Bill Frankos, Herbalife;

  • Laura Harkness, Church and Dwight;

  • Daniel Hassan, Physician’s Seal;

  • David Hilton, Natrol;

  • Mark Hornick, Jamieson Wellness;

  • Kirk Jowers, doTERRA International*;

  • Harvey Kamil, Nature’s Bounty (chair emeritus);

  • Randy King, Procter & Gamble/New Chapter;

  • Allison Levy, AdvoCare International, LP* (treasurer);

  • Ken Myers, Nu Skin Enterprises;

  • Scott Ravech, Deerland Probiotics & Enzymes*;

  • Barry Ritz, Atrium Innovations* (chair-elect);

  • Craig Sheehan, Activ Nutritional;

  • Brian Smith, MeriCal;

  • Nancy Steely, Arbonne International;

  • Michelle Stout, Amway/Nutrilite;

  • Ben Teicher, Healthy Directions;

  • Tu Tran, Pharma Tech Industries;

  • Robert Uccardi, Pfizer Consumer Healthcare; and

  • Danielle Virant, Abbott Nutrition


Suppliers:

  • David Blackwood, DSM Nutritional Products*;

  • Kevin Boot, Embria Health Sciences;

  • Bruce Brown, Natreon;

  • Sandy Chien, HORN Nutraceuticals;

  • Leo Cullen, Kyowa Hakko U.S.;

  • Sherry Duff, Innophos;

  • Jim Hamilton, Neptune Wellness Solutions;

  • Jim Hyde, Balchem Human Nutrition & Pharma* (immediate past chair);

  • James Komorowski, Nutrition 21;

  • Micah Osborne, Stratum Nutrition*;

  • Beth Tormey, Lonza; and

  • Jim Watson, Watson (secretary)


Campbell also appointed the following committee chairs:

  • Audit committee: Jim Hamilton, Neptune Wellness Solutions

  • Communications and media outreach committee: Ruth Winker, Jamieson Wellness;

  • CRN political action committee: Allison Levy, Advocare International;

  • Government relations committee: Bethany Davis, FoodState;

  • International trade and market development committee: Christine Beltran, doTERRA International (chair), and Scott Mobley, Clorox (vice chair);

  • Legal committee: Greg Fortsch, Nature’s Bounty;

  • Membership committee: Scott Ravech, Deerland Probiotics & Enzymes;

  • Personnel and compensation committee: Paul Bolar, Pharmavite;

  • Regulatory affairs committee: Russell Michelson, Pfizer Consumer Health (chair), and Danielle Citrolo, Kyowa Hakko U.S. (co-chair); and

  • Senior scientific advisory council: Annahita Ghassemi, Church & Dwight (chair), and Susan Mitmesser, Pharmavite (vice chair)